Nothing Special   »   [go: up one dir, main page]

Hollenbaugh et al., 2003 - Google Patents

Use of monoclonal antibodies for expression cloning

Hollenbaugh et al., 2003

Document ID
12884362982292868326
Author
Hollenbaugh D
Aruffo A
Jones B
Linsley P
Publication year
Publication venue
Current Protocols in Molecular Biology

External Links

Snippet

This unit details the use of transient expression in mammalian cells to screen cDNA libraries with monoclonal antibodies (MAb) to isolate cDNA clones encoding cell‐surface and intracellular proteins. The first protocol in this unit describes the cloning of cDNAs encoding …
Continue reading at currentprotocols.onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
EP0330191B1 (en) DNA encoding CD40
Ingegnere et al. Human CAR NK cells: a new non-viral method allowing high efficient transfection and strong tumor cell killing
Cheadle et al. Chimeric antigen receptors for T-cell based therapy
Riet et al. Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy
JP6683598B2 (en) Methods and compositions for producing stable transfected cells
WO1997032601A1 (en) Method of screening apoptosis inducing substances
WO2018233589A1 (en) Method for preparing clinical-grade car-t cell preparation by transfecting t cell with minicircle dna
CN114163537B (en) Chimeric antigen receptor T cell secreting bispecific antibody, and preparation method and application thereof
CN111954684A (en) CAR-T cells and autoimmune diseases
Pedrazzoli et al. Cell fusion in tumor progression: the isolation of cell fusion products by physical methods
CN111484563B (en) anti-CD 38 chimeric antigen receptor and application thereof
Hollenbaugh et al. Use of monoclonal antibodies for expression cloning
Hollenbaugh et al. Use of monoclonal antibodies for expression cloning
CN111983218A (en) Kit for detecting interaction of living cell-living cell surface receptor-ligand
WO2012178150A2 (en) Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies
CN113980143B (en) Chimeric antigen receptor, chimeric antigen receptor T cell targeting CD276, preparation method and pharmaceutical application
CN109136284B (en) AFFT2 cell
WO2020232418A1 (en) Intracellular delivery
WO2023184616A1 (en) Method for detecting cloned tcr sequence and use thereof
Wu et al. Barcode clonal tracking of tissue-resident immune cells in rhesus macaque highlights distinct clonal distribution pattern of tissue NK cells
US20230181641A1 (en) Process for producing donor-batched cells expressing a recombinant receptor
US20220412954A1 (en) Methods of determining attributes of therapeutic t cell compositions
Pan et al. Cloning muscle isoforms of neural cell adhesion molecule using an episomal shuttle vector
WO2008118926A1 (en) A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
CN113999320B (en) CD 276-targeted chimeric antigen receptor taking CD28 and 4-1BB as co-stimulation domains and application thereof